Alexandria Real Estate Equities, Inc. (ARE) is a leading life-sciences real estate investment trust (REIT) headquartered in Pasadena, California. The company specializes in developing and operating innovative Megacampus ecosystems, primarily leasing office and laboratory spaces to biotechnology, pharmaceutical, and tech firms in top research hubs such as Greater Boston, San Francisco, San Diego, Seattle, Maryland, and the Research Triangle. Alexandria has a market cap of around $8.6 billion.
Shares of this REIT have significantly lagged behind the broader market. Over the past 52 weeks, ARE stock has declined 52.6%, while the broader S&P 500 Index ($SPX) has gained 12.3%. Moreover, on a year-to-date (YTD) basis, the stock is down 49.3%, compared to SPX’s 12.9% rise.
